WARNING: This product contains nicotine. Nicotine is an addictive chemical. For adults 21+ only.
★CNP★
news

FDA-Authorized Nicotine Pouches in 2026: The Complete List

43 pouch products hold FDA marketing authorization as of August 2026: 20 ZYN, 11 ZYN Ultra, 6 on! PLUS and 6 on! Everything else is pending PMTA review.

By Sarah Chen

TL;DR

As of FDA's list current through August 21, 2026, 43 nicotine pouch products have FDA marketing authorization in the United States: 20 from ZYN (authorized January 2025), 11 from ZYN Ultra (authorized August 2026), 6 from on! PLUS (authorized December 2025), and 6 from the original on! line. All other nicotine pouches on the US market are either pending PMTA review or operating without FDA authorization. Below is the complete list, what authorization actually means, and what's coming next.

"FDA approved" vs "FDA authorized" — the distinction matters

The phrase "FDA approved nicotine pouches" appears in countless searches, but it's technically wrong. The FDA does not "approve" tobacco products; that term is reserved for pharmaceuticals.

For nicotine pouches, the correct term is FDA marketing authorization, granted via a Marketing Granted Order under the Premarket Tobacco Product Application (PMTA) pathway. Authorization means the FDA determined a product is "appropriate for the protection of public health" — not that it is safe, healthy, or recommended.

The FDA itself emphasizes this. In its December 2025 announcement on on! PLUS, the agency reiterated that authorization does not mean products are safe or "FDA approved," and that no tobacco product is risk-free.

The full list of FDA-authorized nicotine pouch SKUs

ZYN (authorized January 2025)

20 SKUs total — 10 flavors at 3mg and 6mg strengths each:

Flavor3mg6mg
Chill✓✓
Cinnamon✓✓
Citrus✓✓
Coffee✓✓
Cool Mint✓✓
Menthol✓✓
Peppermint✓✓
Smooth✓✓
Spearmint✓✓
Wintergreen✓✓

ZYN Ultra (authorized August 2026)

11 products — the high-strength tier, authorized on August 21, 2026. Note the asymmetry: ten flavors are authorized at 9mg, but only Smooth is authorized at 11mg.

Flavor9mg11mg
Chill✓—
Citrus✓—
Cool Mint✓—
Deep Freeze✓—
Menthol✓—
Peppermint✓—
Smooth✓✓
Spearmint✓—
Wintergreen✓—
Wintergreen Chill✓—

ZYN markets the Ultra line under different retail names than FDA uses on the authorization list — the cans on shelves say Citrus Zest, Arctic Mint, Signature Smooth and so on. Per ZYN's own site, every Ultra variety is sold in both 9mg and 11mg, which means some 11mg cans on shelves are not on FDA's authorized list.

on! PLUS (authorized December 2025)

6 SKUs — 3 flavors at 6mg and 9mg strengths each:

Flavor6mg9mg
Mint✓✓
Tobacco✓✓
Wintergreen✓✓

on! original line

6 SKUs — 3 flavors at 2mg and 4mg strengths each:

Flavor2mg4mg
Autumn Spice✓✓
Cappuccino✓✓
Rich Berry✓✓

on! sells more flavors than these three at retail. Only these three appear on FDA's authorized list.

What's pending in the FDA's PMTA pilot program

In September 2025, the FDA launched a pilot program to accelerate PMTA review for nicotine pouches. The pilot includes products from major manufacturers:

  • on! and on! PLUS (Helix Innovations / Altria) — first authorizations issued December 2025
  • ZYN Ultra (Swedish Match / Philip Morris International) — authorized August 21, 2026 (11 products)
  • VELO mini (R.J. Reynolds) — pending
  • FRE (Turning Point Brands) — pending
  • ALP (Turning Point Brands) — pending

The pilot is designed to speed reviews while maintaining the same scientific standards. Additional decisions are expected throughout 2026.

What this means for consumers

Authorization is not safety. Even authorized products carry the standard FDA nicotine warning: "This product contains nicotine. Nicotine is an addictive chemical."

Availability can change. Products without PMTA authorization face removal from the US market. State-level enforcement is intensifying — California, for example, restricts flavored tobacco products including pouches, and several other states have introduced product registry laws.

Tax landscape is shifting. At least 20 states introduced excise taxes on nicotine pouches in 2025, and 2026 is expected to bring additional legislation. Federal taxes remain limited but state rates vary widely.

What this means if you're shopping

If long-term availability matters to you, FDA-authorized brands (ZYN and on! PLUS) are the safest bet. If you're in California or another state with flavor restrictions, check current state law before ordering — some flavored authorized products may still be unavailable in your state due to local rules.

For current product reviews and side-by-side comparisons, see our reviews and comparisons sections.

Common questions

Frequently Asked Questions

No nicotine pouch is 'FDA approved.' That phrase doesn't apply to tobacco products. The correct term is 'FDA authorized,' which means the FDA has issued a Marketing Granted Order under the PMTA pathway. As of FDA's August 21, 2026 list, 43 nicotine pouch products have FDA authorization: 20 ZYN, 11 ZYN Ultra, 6 on! PLUS and 6 on!
ZYN was the first nicotine pouch brand to receive FDA marketing authorization, in January 2025. The FDA authorized 20 ZYN SKUs across 10 flavors at 3mg and 6mg strengths.
No. 'FDA approved' is reserved for drugs and medical devices. Tobacco products like nicotine pouches receive 'FDA marketing authorization' or 'PMTA authorization' — meaning the FDA determined the product meets the public health standard required by law, not that the product is safe or approved as a treatment.
Authorization affects long-term availability. Brands without authorization can be removed from the US market. State-level enforcement is also tightening — many states maintain registries of authorized products that retailers must check before selling.
VELO mini, Zyn Ultra, FRE, and ALP are part of the FDA's nicotine pouch PMTA pilot program announced in September 2025. Decisions are expected throughout 2026. Other brands including Rogue, Lucy, Juice Head, and Fully Loaded have submitted PMTAs but are not in the accelerated pilot.